ALKS vs TROW · P/E 14, rev $1.56B vs P/E 12, rev $7.09B
Alkermes Plc (ALKS) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported TROW revenue for 2024-12-31 was $7.09B. Net income was $2.14B. Revenue was up 9.8% from 2023-12-31 to 2024-12-31. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the ALKS and TROW stock pages for the full models.
Not investment advice.